Doximity, Inc.
General ticker "DOCS" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $9.0B (TTM average)
Doximity, Inc. does not follow the US Stock Market performance with the rate: -24.2%.
Estimated limits based on current volatility of 2.1%: low 20.64$, high 21.53$
Factors to consider:
- Earnings expected soon, date: 2026-08-06 amc
- Total employees count: 880 (+6.0%) as of 2026
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Strategic risks and growth management, Limited operating history, Member retention failure, Customer renewals, Customer concentration
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-03-31 to 2028-03-30
- 2026-03-31 to 2027-03-31 estimated range: [18.70$, 39.60$]
- 2027-03-31 to 2028-03-30 estimated range: [17.17$, 35.32$]
Financial Metrics affecting the DOCS estimates:
- Positive: with PPE of 15.8 at the end of fiscal year the price was neutral
- Positive: Operating profit margin, % of 33.33 > 18.65
- Positive: 6.73 < Operating cash flow per share per price, % of 7.24
- Positive: Industry inventory ratio change (median), % of -0.06 <= 0
- Negative: Shareholder equity ratio, % of 84.62 > 63.79
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 3.26 > -0.65
- Negative: Inventory ratio change, % of 2.57 > 0.80
Short-term DOCS quotes
Long-term DOCS plot with estimates
Financial data
| YTD | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|
| Operating Revenue | $475.42MM | $570.40MM | $644.86MM |
| Operating Expenses | $311.54MM | $342.60MM | $429.94MM |
| Operating Income | $163.88MM | $227.80MM | $214.92MM |
| Non-Operating Income | $21.32MM | $35.77MM | $35.09MM |
| R&D Expense | $81.98MM | $93.04MM | $130.70MM |
| Income(Loss) | $185.20MM | $263.57MM | $250.00MM |
| Taxes | $37.62MM | $40.39MM | $53.95MM |
| Net Income(Loss)* | $147.58MM | $223.19MM | $196.05MM |
| Stockholders Equity | $901.40MM | $1,082.62MM | $950.84MM |
| Assets | $1,079.37MM | $1,264.31MM | $1,123.69MM |
| Operating Cash Flow | $184.10MM | $273.26MM | $326.46MM |
| Capital expenditure | $5.80MM | $6.53MM | $8.96MM |
| Investing Cash Flow | $31.19MM | $-29.30MM | $147.17MM |
| Financing Cash Flow | $-276.52MM | $-131.14MM | $-464.06MM |
| Earnings Per Share** | $0.78 | $1.19 | $1.05 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.